Interested In Trying a New Migraine Abortive? Trials Are Now Open!

(Interested In Trying a New Migraine Abortive? The Trials Are Open!) UPDATED 2008-09-26

You may remember that I interviewed Dr. Tony Ho about a new Migraine abortive medication at last year's American Headache Society conference. If you didn't read about it or would like to reread it, see New Migraine Abortive Shows Promise without Vasoconstriction.

The medication is still know by a number, MK0974, and is being developed by Merck. It is now in Phase III clinical trials, the last phase before Merck seeks FDA approval of the medication. In Phase III trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.

Are you interested in being in this trial? Here are the eligibility requirements and criteria...

Continue reading Interested In Trying a New Migraine Abortive? The Trials Are Open!

Read full story >

See all Migraine News